Weston W. Porter

4.4k total citations
63 papers, 3.3k citations indexed

About

Weston W. Porter is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Weston W. Porter has authored 63 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 15 papers in Genetics and 12 papers in Oncology. Recurrent topics in Weston W. Porter's work include Estrogen and related hormone effects (14 papers), Effects and risks of endocrine disrupting chemicals (8 papers) and Epigenetics and DNA Methylation (7 papers). Weston W. Porter is often cited by papers focused on Estrogen and related hormone effects (14 papers), Effects and risks of endocrine disrupting chemicals (8 papers) and Epigenetics and DNA Methylation (7 papers). Weston W. Porter collaborates with scholars based in United States, Canada and United Kingdom. Weston W. Porter's co-authors include Stephen Safe, Renqin Duan, Richard P. Metz, Debie J. Hoivik, Luis Cisneros‐Zevallos, David Byrne, Giuliana Noratto, Venkatesh Krishnan, Pepper Schedin and Andrew McDougal and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Development.

In The Last Decade

Weston W. Porter

60 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weston W. Porter United States 30 1.6k 1.0k 592 588 583 63 3.3k
Deodutta Roy United States 27 1.5k 0.9× 913 0.9× 418 0.7× 423 0.7× 552 0.9× 88 2.8k
Adele Vivacqua Italy 31 1.6k 1.0× 1.7k 1.7× 232 0.4× 708 1.2× 499 0.9× 56 3.3k
W.G.E.J. Schoonen Netherlands 33 1.1k 0.6× 859 0.8× 456 0.8× 368 0.6× 420 0.7× 78 3.5k
Saveria Aquila Italy 39 1.7k 1.0× 930 0.9× 156 0.3× 442 0.8× 677 1.2× 110 4.4k
Julie M. Hall United States 21 1.5k 0.9× 2.3k 2.2× 541 0.9× 810 1.4× 362 0.6× 40 3.7k
Monica M. Montano United States 33 2.1k 1.3× 2.2k 2.1× 532 0.9× 812 1.4× 382 0.7× 69 4.4k
David Pulford United Kingdom 13 3.2k 2.0× 564 0.5× 302 0.5× 394 0.7× 338 0.6× 17 4.5k
Robert C. Smart United States 33 2.1k 1.3× 309 0.3× 228 0.4× 522 0.9× 753 1.3× 68 4.0k
Gilles Flouriot France 33 1.6k 1.0× 2.4k 2.3× 512 0.9× 737 1.3× 341 0.6× 88 4.3k
Anders Ström Sweden 36 2.4k 1.5× 2.9k 2.8× 311 0.5× 1.5k 2.5× 815 1.4× 68 5.4k

Countries citing papers authored by Weston W. Porter

Since Specialization
Citations

This map shows the geographic impact of Weston W. Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weston W. Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weston W. Porter more than expected).

Fields of papers citing papers by Weston W. Porter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weston W. Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weston W. Porter. The network helps show where Weston W. Porter may publish in the future.

Co-authorship network of co-authors of Weston W. Porter

This figure shows the co-authorship network connecting the top 25 collaborators of Weston W. Porter. A scholar is included among the top collaborators of Weston W. Porter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weston W. Porter. Weston W. Porter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Porter, Weston W., et al.. (2024). Immune Cell Contribution to Mammary Gland Development. Journal of Mammary Gland Biology and Neoplasia. 29(1). 16–16. 4 indexed citations
2.
Soma, Shivatheja, Lin Tan, Sara Martínez, et al.. (2023). Noncanonical role of singleminded-2s in mitochondrial respiratory chain formation in breast cancer. Experimental & Molecular Medicine. 55(5). 1046–1063. 3 indexed citations
3.
Wellberg, Elizabeth A., et al.. (2023). SIM2s directed Parkin-mediated mitophagy promotes mammary epithelial cell differentiation. Cell Death and Differentiation. 30(6). 1472–1487. 8 indexed citations
4.
5.
Richer, Jennifer K., et al.. (2020). Hormonal Regulation of Semaphorin 7a in ER+ Breast Cancer Drives Therapeutic Resistance. Cancer Research. 81(1). 187–198. 26 indexed citations
6.
Barhoumi, Rola, et al.. (2019). Loss of SIM2s inhibits RAD51 binding and leads to unresolved replication stress. Breast Cancer Research. 21(1). 125–125. 5 indexed citations
7.
Fan, Yang‐Yi, et al.. (2019). Cross-talk between SIM2s and NFκB regulates cyclooxygenase 2 expression in breast cancer. Breast Cancer Research. 21(1). 131–131. 14 indexed citations
8.
Sarkar, Tapasree Roy, et al.. (2018). ATM-dependent activation of SIM2s regulates homologous recombination and epithelial–mesenchymal transition. Oncogene. 38(14). 2611–2626. 18 indexed citations
9.
Behbod, Fariba, et al.. (2012). Regulation of DCIS to invasive breast cancer progression by Singleminded-2s (SIM2s). Oncogene. 32(21). 2631–2639. 25 indexed citations
10.
Wellberg, Elizabeth A., et al.. (2010). The bHLH/PAS transcription factor singleminded 2s promotes mammary gland lactogenic differentiation. Development. 137(6). 945–952. 19 indexed citations
11.
12.
Qu, Xiaoyu, Richard P. Metz, Weston W. Porter, Vincent M. Cassone, & David J. Earnest. (2008). Disruption of period gene expression alters the inductive effects of dioxin on the AhR signaling pathway in the mouse liver. Toxicology and Applied Pharmacology. 234(3). 370–377. 28 indexed citations
13.
McDaniel, Shauntae M., Kristen K. Rumer, Sandra L. Biroc, et al.. (2006). Remodeling of the Mammary Microenvironment after Lactation Promotes Breast Tumor Cell Metastasis. American Journal Of Pathology. 168(2). 608–620. 179 indexed citations
14.
Metz, Richard P., et al.. (2006). Differential Transcriptional Regulation by Mouse Single-minded 2s. Journal of Biological Chemistry. 281(16). 10839–10848. 27 indexed citations
15.
Liu, Shengxi, Maen Abdelrahim, Kyungsil Yoon, et al.. (2006). Vascular Endothelial Growth Factor Receptor-2 Expression Is Induced by 17β-Estradiol in ZR-75 Breast Cancer Cells by Estrogen Receptor α/Sp Proteins. Endocrinology. 147(7). 3285–3295. 41 indexed citations
16.
Metz, Richard P., Xiaoyu Qu, Brian Laffin, David J. Earnest, & Weston W. Porter. (2005). Circadian clock and cell cycle gene expression in mouse mammary epithelial cells and in the developing mouse mammary gland. Developmental Dynamics. 235(1). 263–271. 49 indexed citations
17.
Porter, Weston W., et al.. (1998). Estrogen-Induced Retinoic Acid Receptor α1 Gene Expression: Role of Estrogen Receptor-Sp1 Complex. Molecular Endocrinology. 12(6). 882–890. 103 indexed citations
18.
Gillesby, Bradley E., et al.. (1997). Identification of a Motif within the 5‘ Regulatory Region of pS2 Which Is Responsible for AP-1 Binding and TCDD-Mediated Suppression. Biochemistry. 36(20). 6080–6089. 117 indexed citations
19.
Krishnan, Venkatesh, Weston W. Porter, Michael J. Santostefano, Xiahong Wang, & Stephen Safe. (1995). Molecular Mechanism of Inhibition of Estrogen-Induced Cathepsin D Gene Expression by 2,3,7,8-Tetrachlorodibenzo- p -Dioxin (TCDD) in MCF-7 Cells. Molecular and Cellular Biology. 15(12). 6710–6719. 172 indexed citations
20.
Wang, Xiaofang, Weston W. Porter, Venkatesh Krishnan, T.R. Narasimhan, & Stephen Safe. (1993). Mechanism of 2,3,7,8-tetrachlorodibenzo-P-dioxin (TCDD)-mediated decrease of the nuclear estrogen receptor in MCF-7 human breast cancer cells. Molecular and Cellular Endocrinology. 96(1-2). 159–166. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026